Peptide record

TPDB05391

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05391
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP pep-lab Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0 APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLPVLAGIAAKVVPALFCKITKKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C121H204N28O26S2
RNDEQHMSWY
AK
2531.24
10.17
4
0
14
+4
-1.19
1.287
134.17
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.05
3
Residue Composition
number
4
A
0
R
0
N
0
D
2
C
0
E
0
Q
1
G
0
H
2
I
3
L
4
K
0
M
2
F
2
P
0
S
1
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 1 H: 0 I: 2 L: 3 K: 4 M: 0 F: 2 P: 2 S: 0 T: 1 W: 0 Y: 0 V: 3
Chemical Descriptors
24 reviewed residue count
C121H204N28O26S2 sequence-only estimate (linear, free termini)
2531.24 sequence-only estimate (linear, free termini)
10.17 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
-1.19 sequence-only estimate (linear, free termini)
1.287 sequence-only estimate (linear, free termini)
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2 µg/mL

Target

B. Subtilis

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain
Evidence 2 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain from the mprF regulating
Evidence 3 Activity

Activity

MIC
Antibacterial
34 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain from the mprF regulating system ( Li et al., 2007 ).
Evidence 4 Activity

Activity

MIC
Antifungal
2 µg/mL

Target

B. Subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain
Evidence 5 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain from the mprF regulating
Evidence 6 Activity

Activity

MIC
Antifungal
34 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain from the mprF regulating system ( Li et al., 2007 ).
Evidence 7 Activity

Activity

MIC
Antiparasitic
2 µg/mL

Target

B. Subtilis

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain
Evidence 8 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain from the mprF regulating
Evidence 9 Activity

Activity

MIC
Antiparasitic
34 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain from the mprF regulating system ( Li et al., 2007 ).
Evidence 10 Activity

Activity

MIC
Antiviral
2 µg/mL

Target

B. Subtilis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain
Evidence 11 Activity

Activity

MIC
Antiviral
8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain from the mprF regulating
Evidence 12 Activity

Activity

MIC
Antiviral
34 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against B. Subtilis (MIC 2 ug/ml), S. aureus (MIC 8 ug/ml), and E. coli (MIC 34 ug/ml). More active against a mutant strain from the mprF regulating system ( Li et al., 2007 ).
Evidence 13 Activity

Activity

Hemolysis
[Ref.1449472] high hemolytic activity

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Biochem Biophys Res Commun. 1992 Nov 30 189(1):184-190.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

89% Hemolysis
Toxicity
80 µg/mL
Hemolytic Cytotoxic
89% Hemolysis | 80 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. | Eur J Clin Microbiol Infect Dis | 2000
Evidence 15 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.1449472] high hemolytic activity

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochem Biophys Res Commun. 1992 Nov 30 189(1):184-190.
Evidence 16 Hemolysis

Activity

[Ref.1449472] high hemolytic activity
Hemolysis

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
Biochem Biophys Res Commun. 1992 Nov 30 189(1):184-190.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.